<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended. . . . . .March 31, 1999
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from. . . . . . . to. . . . .
Commission file number. . . . . . . . . . 0-13591
PROVIDENT AMERICAN CORPORATION
(Exact name of registrant as specified in its charter)
Pennsylvania 23-2214195
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
2500 DeKalb Pike, Norristown, Pennsylvania
19401 (Address of principal executive
offices)
(Zip Code)
Registrant's telephone number, including area code: (610) 279-2500
Former name, former address and former fiscal year,
if changed since last report: N/A
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
APPLICABLE ONLY TO CORPORATE ISSUERS
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date: 12,047,728 shares of common
stock, par value $.10, outstanding as of May 10, 1999.
Page 1 of 35 Pages
<PAGE>
PROVIDENT AMERICAN CORPORATION
INDEX
Page No.
--------
Part I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Consolidated Statements of Operations 3
Consolidated Balance Sheets 4-5
Consolidated Statements of Changes in Stockholders' Equity 6
Consolidated Statements of Cash Flows 7-8
Notes to Condensed Consolidated Financial Statements 9-26
Item 2. Management's Discussion and Analysis of Results
of Operations and Financial Condition 27-33
Part II. OTHER INFORMATION
Items 1- 5 34
Reports on Form 8-K 34
SIGNATURES 35
Exhibit 11
Exhibit 27
Page 2 of 35 Pages
<PAGE>
PART I. FINANCIAL INFORMATION
Item 1. Condensed Financial Statements
Provident American Corporation and Subsidiaries
Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share data)
<TABLE>
<CAPTION>
3 Months Ended March 31,
1999 1998
---------- ----------
<S> <C> <C>
Revenue:
Premium: Accident and health, gross $ 25,472 $ 28,668
Life and annuity, gross 1,696 2,477
---------- ----------
Total gross premium 27,168 31,145
--------- ---------
Accident and health reinsurance ceded 24,989 11,699
Life and annuity reinsurance ceded 466 50
----------- ------------
Total reinsurance ceded 25,455 11,749
--------- ---------
Net premium 1,713 19,397
Net investment income 924 919
Realized gain on the sale of subsidiary 1,500 4,000
Other revenue 296 205
----------- -----------
Total revenue 4,433 24,520
---------- ---------
Benefits and expenses:
Death and other policy benefits:
Life 1,390 1,113
Accident and health, net of reinsurance 405 12,096
Annuity contracts and other considerations (130) 88
Increase (decrease) in liability for future policy benefits 477 (2)
Commissions, net of ceding allowance and deferred acquisition costs 257 2,792
Other operating expenses, net of ceding allowance
and deferred acquisition costs 4,811 5,261
Amortization of deferred policy acquisition costs 119 233
Depreciation and amortization of goodwill 322 226
------------ -----------
Total benefits and expenses 7,651 21,807
----------- ---------
(Loss) income before taxes and minority interest (3,218) 2,714
Provision for income taxes:
Current 15 41
Deferred 0 0
-------------- ------------
Total income taxes 15 41
------------- -----------
Net (loss) income before minority interest (3,233) 2,673
Minority interest net loss of subsidiary 366 0
------------ ------------
Net (loss) income (2,867) 2,673
------------ ---------
Dividends on preferred stock 164 37
------------- -----------
Net (loss) income applicable to common stock (3,031) 2,636
============= =========
(Loss) income per share of common stock
Basic ($0.26) $ 0.26
============= =========
Diluted ($0.26) $ 0.22
============= =========
Common shares and equivalents used in computing (loss) income per share
Basic 11,614,000 10,173,000
Diluted 11,614,000 11,787,000
</TABLE>
See notes to consolidated financial statements.
Page 3 of 35 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Balance Sheets
(Dollars in thousands, except preferred and common stock data)
<TABLE>
<CAPTION>
UNAUDITED
March 31, 1999 December 31, 1998
-------------- -----------------
<S> <C> <C>
Assets
Investments:
Securities available for sale $ 30,842 $ 31,880
Policy loans 567 560
Other invested assets 524 529
---------- ----------
Total Investments 31,933 32,969
Cash and cash equivalents 15,643 26,185
Amounts due from third party administrator 0 6,849
Premiums due and uncollected 884 1,167
Amounts due from reinsurers 36,513 22,222
Loans receivable from officer, director and stockholder 634 1,328
Accrued investment income 324 420
Prepaid interactive marketing expense 11,773 11,655
Property and equipment, less accumulated depreciation of $3,421 and $3,099 7,764 7,950
Unamortized deferred policy acquisition costs 2,213 2,106
Other assets 2,943 3,838
---------- ----------
Total Assets $ 110,623 $ 116,689
========== ==========
</TABLE>
Continued on next page. See
notes to consolidated financial statements.
Page 4 of 35 Pages
<PAGE>
<TABLE>
<CAPTION>
Provident American Corporation and Subsidiaries
Consolidated Balance Sheets (Continued)
(Dollars in thousands, except preferred and common stock data)
UNAUDITED
March 31, 1999 December 31, 1998
-------------- -----------------
<S> <C> <C>
Liabilities and Stockholders' Equity
Future policy benefits:
Life $ 42,815 $ 42,546
Annuity and other 4,836 4,871
Policy claims 32,936 42,481
Premiums received in advance and unearned (31) 335
Amounts due to reinsurers 737 501
Accounts payable 768 2,107
Accrued commissions and expenses 2,878 2,384
Loans payable 1,267 3,865
Federal income taxes 1,050 1,222
Ceding commission liability 5,150 5,000
Other liabilities 2,179 1,945
--------- ---------
Total Liabilities 94,584 107,257
Commitments and Contingencies:
Minority Interest in HealthAxis.com, Inc.:
Minority interest in HealthAxis.com, Inc. common stock 867 1,132
HealthAxis.com, Inc. preferred stock - Cumulative preferred stock, par
value $1:
authorized 5,000,000 shares:
Series B , issued 625,529 2,934 2,805
Series C, issued 1,526,412 and 0 7,719 0
Stockholders' Equity
Preferred stock, par value $1: authorized 20,000,000 shares:
Series A Cumulative convertible, issued 580,250 557 557
Series B Cumulative convertible, none issued 0 0
Common stock, par value $.10: authorized 50,000,000, issued 11,787,546 and
11,488,911 1,179 1,149
Common stock, Class A, par value $.10: authorized 20,000,000, none issued 0 0
Additional paid-in capital 29,375 27,002
Accumulated other comprehensive income 318 666
Retained earnings (26,910) (23,879)
--------- ---------
Total Stockholders' Equity 4,519 5,495
--------- ---------
Total Liabilities and Stockholders' Equity $ 110,623 $ 116,689
========= =========
</TABLE>
See notes to condensed financial statements.
Page 5 of 35 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Statements of Changes in Stockholders' Equity (Unaudited)
(in thousands)
<TABLE>
<CAPTION>
Accumulated
Preferred Stock Common Stock Additional Retained Other Treasury
Paid-In Earnings Comprehensive Stock
Shares Amount Shares Amount Capital (Deficit) Income (Loss) (at cost) Total
------- -------- ------- ------- ------- --------- -------------- ---------- -------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C>
BALANCE, DECEMBER 31, 1998 557 $ 557 11,489 $ 1,149 $ 27,002 $ (23,879) $ 666 $ 0 $ 5,495
Comprehensive income:
Net income (loss) (2,867) (2,867)
Other comprehensive
income (loss) (348) (348)
-------
Comprehensive income (3,215)
-------
Issuance of common stock 25 3 267 270
Stock options and warrants
exercised 274 27 1,481 1,508
Increase in net assets in
HealthAxis.com, Inc. 625 625
Cash dividends declared on
preferred stock (164) (164)
---- ----- ------- ------- -------- ---------- ----- ----- -------
BALANCE, MARCH 31, 1999 557 $ 557 11,788 $ 1,179 $ 29,375 $ (26,910) $ 318 $ 0 $ 4,519
===== ===== ======= ======= ======== ========== ===== ===== =======
</TABLE>
See notes to consolidated financial statements.
Page 6 of 35 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Unaudited)
(Dollars in thousands)
<TABLE>
<CAPTION>
3 Months Ended March 31,
1999 1998
-------- ---------
<S> <C> <C>
Cash flows from operating activities
Net income (loss) $ (2,867) $ 2,673
Adjustments to reconcile net income (loss) to net cash
provided by (used in) operating activities:
Issuance of common stock per Employment Contract 90 0
Depreciation and amortization 1,695 229
Net realized (gain) on sale of subsidiary (1,500) (4,000)
Net loss in minority interest (366) 0
Decrease (increase) in:
Premium due and uncollected, unearned
premium and premium received in advance (83) (2,050)
Prepaid interactive marketing expense (1,500) 0
Due to/from reinsurers (14,055) (4,756)
Due from third party administrator 6,849 (5,391)
Deferred policy acquisition costs, net (107) (1,062)
Accrued investment income 96 35
Other assets, current and deferred income
taxes and other liabilities (1,434) (1,050)
Accrued commissions and expenses 494 (986)
Unearned ceding commissions 150 0
Future policy benefits and claims (9,312) 12,298
--------- --------
Net cash used in operating activities (21,850) (4,060)
--------- --------
Cash flows from investing activities
Purchases of bonds 0 (1,676)
Sale of bonds 512 2,104
Sale of subsidiaries 0 4,000
Maturity of investments and loans (2) 0
Repayments of loans receivable 0 3
Loans to officer, director and shareholder 694 (22)
Purchases of property and equipment (136) (298)
--------- ---------
Net cash provided by investing activities 1,068 4,111
--------- --------
</TABLE>
Continued on next page.
See notes to consolidated financial statements.
Page 7 of 35 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Continued)
(Dollars in thousands)
<TABLE>
<CAPTION>
3 Months Ended March 31,
1999 1998
--------- -----------
<S> <C> <C>
Cash flows from financing activities
Withdrawals from contractholder deposit funds 0 (589)
Repayments of loans payable (198) (132)
Issuance of common stock 0 4
Issuance of HealthAxis preferred stock, net 8,807 0
Exercise of stock options 1,666 0
Dividends paid on preferred and common stock (35) (37)
-------- --------
Net cash from financing activities 10,240 (755)
-------- --------
Decrease in cash and cash equivalents (10,542) (703)
Cash and cash equivalents, beginning of period 26,185 16,767
-------- --------
Cash and cash equivalents, end of period $ 15,643 $ 16,064
======== ========
Supplemental disclosure of cash flow information:
Interest paid $ 269 $ 52
Non cash investing activities
Sale of subsidiary 1,500 0
Non-cash financing activities:
Issuance of warrants $ 724 $ 990
Exercise of options and warrants $ 1,509 $ 0
Repayment of loans payable $ (2,400) 0
</TABLE>
See notes to consolidated financial statements.
Page 8 of 35 Pages
<PAGE>
Provident American Corporation and Subsidiaries
Notes to Condensed Consolidated Financial Statements
(Dollars in thousands)
Note A - General
The condensed consolidated financial statements have been prepared by
Provident American Corporation and subsidiaries (the "Company") without audit,
pursuant to the rules and regulations of the Securities and Exchange Commission
and reflect all adjustments which, in the opinion of the Company, are necessary
to present fairly results for the interim periods. Certain financial information
and footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles have been condensed or
omitted pursuant to such rules and regulations, although the Company believes
that the accompanying disclosures are adequate to make the information presented
not misleading. Results of operations for the three-month period ended March 31,
1999, are not necessarily indicative of the results that may be expected for the
year ending December 31, 1999.
These financial statements should be read in conjunction with the
financial statements and notes thereto contained in the Company's Annual Report
on Form 10-K/A for the year ended December 31, 1998.
Certain prior year amounts have been reclassified to conform with the
current presentation.
Provident American Corporation ("PAMCO") is a Pennsylvania corporation
organized in 1982 and regulated as an insurance holding company by the states in
which its wholly owned insurance subsidiary is licensed. The operations of the
Company are principally those of its majority-owned subsidiary HealthAxis.com,
Inc. ("HealthAxis") and its insurance operations. PAMCO's insurance operations
are conducted through its wholly owned life insurance company Provident
Indemnity Life Insurance Company ("PILIC") and PILIC's subsidiaries which during
1996 through 1998 were Provident American Life and Health Insurance Company
("PALHIC"), Montgomery Management Corporation ("MMC") and NIA Corporation
("NIA"). Hereinafter, PAMCO and all of its subsidiaries are collectively
referred to as the Company and PILIC and all of its subsidiaries are referred to
as the Company's Insurance Operations. During 1998, the Company sold 80% of
MMC's outstanding common stock and on December 31, 1998 sold 100% of the
outstanding common stock of PALHIC and NIA. During the first quarter of 1999 the
Company sold the remaining 20% of MMC's common stock.
Note B - Losses and Uncertainties
Page 9 of 35 Pages
<PAGE>
The Company has incurred costs to develop and enhance its technology,
to create and introduce its website and to establish marketing, insurance
carrier and claims administration relationships. As a result, the Company has
incurred significant losses and expects to continue to incur losses on a
quarterly basis at least through 2000. The Company currently intends to
substantially increase its operating expenses as a result of its strategic
alliances, to fund increased sales and marketing, to enhance its existing web
site and to fund increased salaries and other costs. Consequently, the Company
expects negative cash flow from operations to continue for the foreseeable
future as it continues to develop and market its Internet-based health and life
insurance business.
During 1999, HealthAxis completed a private placement offering of
approximately $8,800 of HealthAxis Series C Preferred Stock (described in Note
F) and approximately $6,200 of HealthAxis common stock (described in Note J)
solely to "accredited investors" (as defined in Rule 501 of Regulation D under
the Securities Act). The net proceeds are anticipated to be used to fund amounts
due under the Company's distribution agreements with America Online, Inc.
("AOL"), Lycos, Inc. ("Lycos"), CNet, Inc. ("CNet") and SNAP Inc. ("SNAP")
through the end of fiscal 1999, and the balance is intended to be used by
HealthAxis for its working capital and other general purposes. The Company
believes that the net proceeds together with its current cash and cash
equivalents will be sufficient to fund current operations and amounts due to
AOL, Cnet, SNAP and Lycos during 1999. However, subsequent equity or debt
financings may be necessary to enable the Company to continue to implement its
current business strategies.
Note C - Changes in Web Alliances
On April 14, 1999, the Company and CNet amended the Promotion Agreement
dated June 14, 1998, as amended on November 13, 1998 (the "Amended Agreement")
to, among other things, revise the current payment schedule and to add Snap! LLC
("Snap") as a party to the agreement, as CNet and Snap are now separate
entities. The Amended Agreement extends the termination date of the initial term
of the agreement to August 31, 2000; allocates the total number of monthly
impressions between Snap and CNet; provides CNet and Snap with the ability to
immediately terminate the Amended Agreement for nonpayment of fees due or to
charge interest on all unpaid amounts at a rate of 1-1/2% per month; revises the
exclusivity provisions of the Amended Agreement; and revises the payment
schedule applicable to the optional term. The Amended Agreement also provides
for the permanent placement of a Company banner on the Snap Health Insurance
Center to be created within the Business and Money Channel on the Snap website
and provides that HealthAxis and Snap shall work together to develop a
co-branded site.
Note D - Prepaid Interactive Marketing Expense
During 1999, HealthAxis made payments aggregating $1,500, which have
been charged, to prepaid interactive marketing expense. These payments were made
under the terms of the Second Amendment (the "Second Amendment") to the Amended
and Restated Interactive Marketing Agreement with AOL and represent exclusivity
and impression advertising costs of $600 and $900, respectively. Included in
Other operating expenses, net of ceding allowance and deferred acquisition costs
is amortization of prepaid interactive marketing expense of $1,380 consisting of
exclusivity expense and impression advertising of $727 and $653, respectively
for 1999.
Page 10 of 35 Pages
<PAGE>
Note E - Minority Interest in HealthAxis.com, Inc.
As of March 31, 1999 and December 31, 1998, 16,172,760 shares of
HealthAxis common stock were issued and outstanding. Of this amount, 13,807,395
or approximately 85% were held by PAMCO and 2,365,365 or approximately 15% were
held by HPS. The minority interest in HealthAxis represents HPS' approximate 15%
of HealthAxis' equity. As described in Note J, the Company has agreed to
purchase 1,415,000 shares of HealthAxis common stock from HPS. Outstanding
shares of HealthAxis common exclude options and warrants to purchase HealthAxis
common stock and HealthAxis convertible preferred stock convertible into
HealthAxis common stock.
The HealthAxis.com, Inc. cumulative preferred stock, par value $1
Series B ("HealthAxis Series B Preferred Stock) held by AOL as described in Note
F and Series C ("HealthAxis Series C Preferred Stock") as described in Note G
are also treated as minority interest.
Note F - HealthAxis.com, Inc. Series B Cumulative Convertible Preferred Stock
During 1998, HealthAxis issued 625,529 shares of HealthAxis Series B
Preferred Stock to AOL at $4.40 per share for an aggregate purchase price of
$2,750, less issuance costs amounting to $51, of which a portion of such net
proceeds was used to pay amounts due to AOL under the IM Agreement. The terms of
the HealthAxis Series B Preferred Stock are as follows:
Dividends. As of March 30, 1999, HealthAxis accrued $235 of unpaid
dividends. Prior to March 30, 1999, holders of the Series B Preferred Stock were
entitled to cumulative dividends accruing from the date of issuance, as and if
declared by the HealthAxis board of directors out of funds legally available
therefor, at the annual rate of $.13 per share (subject to equitable adjustment
to reflect stock splits, stock dividends, stock combinations, recapitalizations
and similar occurrences). Dividends on the HealthAxis Series B Preferred Stock
are computed on the basis of the actual number of days lapsed for any period
less than a full year. If all accrued dividends on the HealthAxis Series B
Preferred Stock have not been paid or set apart for payment: (i) no dividends or
other distributions may be declared and paid or set apart for payment upon the
HealthAxis Common Stock, HealthAxis Series A Preferred Stock or any other class
of securities of HealthAxis having a dividend or distribution preference junior
to the HealthAxis Series B Preferred Stock (the "HealthAxis Series B Junior
Stock"); and (ii) HealthAxis shall not repurchase, redeem or otherwise acquire
any shares of its HealthAxis Common Stock, HealthAxis Series A Preferred Stock
or any series of HealthAxis Series B Junior Stock, other than the repurchase by
HealthAxis of HealthAxis Common Stock from any HealthAxis employee upon the
cessation of the employee's employment with HealthAxis. Holders of HealthAxis
Series B Preferred Stock are not entitled to participate in any other dividends
or other distributions (cash, stock or otherwise) declared or paid on or with
respect to the HealthAxis Common Stock or any other class of stock of
HealthAxis.
Page 11 of 35 Pages
<PAGE>
Following March 30, 1999, holders of the HealthAxis Series B Preferred
Stock are entitled to receive such dividends as declared by the Board of
Directors of HealthAxis in its discretion, out of funds legally available for
that purpose, provided that, such dividend if payable in cash shall be at least
equal to $0.13 per share unless dividends per share in excess of $0.13 per share
are paid to any other holder of capital stock of HealthAxis in which event the
dividend payable to each holder of the HealthAxis Series B Preferred Stock shall
equal $0.13 per share plus an amount equal to such holder's pro rata portion of
any dividend declared by the Board of Directors of HealthAxis and payable to all
other holders of capital stock in excess of $0.13 per share. Dividends on each
share of HealthAxis Series B Preferred Stock, if and when declared, shall accrue
from the applicable date of declaration so that if at any time accrued dividends
upon the HealthAxis Series B Preferred Stock shall not have been paid, the
amount and deficiency in such dividends shall be fully paid (but without
interest) with respect to dividends which have been declared on the shares of
the HealthAxis Series B Preferred Stock or the HealthAxis Series B Junior Stock
and a sum sufficient for the payment thereof shall have been set apart for such
payment, before any dividend shall be declared or paid or any other distribution
ordered or made shares of HealthAxis Common Stock or any HealthAxis Series B
Junior Stock, and before any sum or sums shall be set aside for or applied to
the purchase or redemption of any shares of HealthAxis Common Stock or the
HealthAxis Series B Junior Stock, other than the repurchase by HealthAxis of
shares of HealthAxis Common Stock from any employee thereof upon cessation of
their employment, which shall under all circumstances be permitted
notwithstanding the foregoing.
Liquidation. In the event of any dissolution, liquidation or winding up
of the affairs of HealthAxis, whether voluntary or otherwise, after payment or
provision for payment of the debts and other liabilities of HealthAxis, the
holders of the HealthAxis Series B Preferred Stock shall be entitled to receive,
out of the assets of HealthAxis legally available for distribution to its
shareholders, the amount of approximately $4.40 in cash for each share of
HealthAxis Series B Preferred Stock, plus an amount equal to all dividends
accrued and unpaid on each such share up to the date fixed for distribution,
before any distribution may be made to the holders of HealthAxis' HealthAxis
Common Stock, or any series of HealthAxis Series B Junior Stock, including the
HealthAxis Series A and HealthAxis Series C Preferred Stock. If, after payment
or provision for payment of the debts and other liabilities of HealthAxis, the
remaining net assets of HealthAxis are not sufficient to pay the holders of the
HealthAxis Series B Preferred Stock the full amounts of their preference, the
holders of HealthAxis Series B Preferred Stock would share ratably in any
distribution of assets. After payment or provision for payment of the debts and
other liabilities of HealthAxis and the full preference amount due to the
holders of any HealthAxis Series A, HealthAxis Series B and HealthAxis Series C
Preferred Stock, the holders of the HealthAxis Series B Preferred Stock, the
HealthAxis Series C Preferred Stock, the HealthAxis Series A Preferred Stock and
the HealthAxis Common Stock will be entitled to receive on a pro rata basis the
remaining assets of HealthAxis available for distribution to its shareholders.
The relative value of a share of HealthAxis Series A, B and C Preferred Stock
for this purpose shall be determined on an "as converted" basis.
Page 12 of 35 Pages
<PAGE>
The consolidation or merger of HealthAxis with any corporation (other
than a transaction where holders of HealthAxis' voting capital stock hold a
majority of voting capital of the resulting entity), the sale of all or
substantially all of HealthAxis' assets, the acquisition by any person or entity
of a majority of the voting capital stock of HealthAxis, will be deemed a
liquidation or winding up of HealthAxis.
Optional Redemption. Holders of the HealthAxis Series B Preferred Stock
have the option, exercisable upon request of the holders of 51% of the
outstanding shares of HealthAxis Series B Preferred Stock within six months
after the later of the occurrence of a Trigger Event (as defined below) or
notice of a Trigger Event, to cause HealthAxis to redeem any or all of the
shares of HealthAxis Series B Preferred Stock requested to be redeemed, at a
redemption price per share equal to the original issuance price (subject to
adjustment to reflect stock splits, stock dividends, stock contributions,
recapitalizations and similar occurrences) plus an amount that would yield a
total annualized return of 10% calculated daily and compounded annually from the
later of either the original issuance date or the date on which the holder
acquired the shares of HealthAxis Series B Preferred Stock through the date of
redemption. Notice of the exercise of the optional redemption rights with
respect to the HealthAxis Series B Preferred Stock must be given to HealthAxis
pursuant to the notice of optional redemption provision contained in the
Certificate of Designation related to the HealthAxis Series B Preferred Stock.
A "Trigger Event" means: (i) January 31, 2002, if by that date,
HealthAxis has not consummated an underwritten public offering of newly issued
HealthAxis Common Stock pursuant to a registration statement filed under the
Securities Act, at a net offering price per share of HealthAxis Common Stock
that represents a pre-offering market capitalization of not less than $150.0
million and with aggregate proceeds of not less than $25.0 million, (ii) failure
to renew by HealthAxis or a material breach by any party other than AOL or
termination of the IM Agreement with AOL, (iii) the date of the occurrence of a
liquidation of HealthAxis (as defined above), (iv) March 31, 1999, if by that
date, HealthAxis has not consummated an equity financing yielding aggregate
gross proceeds to HealthAxis of not less than $7.0 million at a price per share
of at least $3.74 (a "Qualified Financing"), or (v) May 31, 1999, if by that
date, HealthAxis has not consummated an equity financing yielding aggregate
gross proceeds to HealthAxis of not less than $3.5 million at a price per share
of at least $3.74 (a "Second Qualified Financing"). As described in Note G,
HealthAxis completed an equity financing in the amount of $8,807 as of March 30,
1999 and as described in Note J HealthAxis completed an equity financing in the
amount of $6,193 on May 11, 1999.
Optional Conversion. Shares of HealthAxis Series B Preferred Stock are
convertible at any time, at the option of the holder, into the number of fully
paid nonassessable shares of HealthAxis Common Stock equal to the quotient
obtained by dividing: (i) the original issuance price by; (ii) the Conversion
Price (as defined below).
The Conversion Price per share will initially be the original issuance
price for the HealthAxis Series B Preferred Stock. The Conversion Price will be
adjusted from time to time in the event: (i) HealthAxis issues, from the
original issuance date through the date of a Second Qualified Financing, any
shares of HealthAxis Common Stock, except for Excluded Stock (as defined below),
Page 13 of 35 Pages
<PAGE>
without consideration or for a consideration per share less than the Conversion
Price in effect immediately prior to that issuance; (ii) at any time after the
Second Qualified Financing date, HealthAxis issues any shares of HealthAxis
Common Stock, except for Excluded Stock (as defined below), without
consideration or for a consideration per share less than the Conversion Price in
effect immediately prior to that issuance; (iii) at any time after the original
issuance date, the number of shares of HealthAxis Common Stock outstanding is
changed by a stock dividend, stock split, combination or capital reorganization.
Excluded Stock means HealthAxis Common Stock: (i) up to 2,900,000
issued to employees, directors and officers of and consultants to HealthAxis
pursuant to agreements approved by the HealthAxis board of directors; (ii)
issued upon conversion of HealthAxis Series A Preferred Stock and HealthAxis
Series B Preferred Stock; (iii) issued by HealthAxis as a stock dividend or upon
any subdivision, split-up or combination of shares of HealthAxis Common Stock;
and (iv) issued in the Qualified Financing provided that the issuance price of
the HealthAxis Common Stock is not less that 85% of the original issuance price.
Whenever HealthAxis adjusts the Conversion Price, HealthAxis will mail
a statement showing in detail the facts requiring the adjustment and the
Conversion Price that will be in effect after the adjustment.
Holders of the HealthAxis Series B Preferred Stock intending to
exercise these conversion rights are required to give notice to HealthAxis in
accordance with the notice requirements set forth in the Certificate of
Designation. No fractional shares will be issued upon conversion, but any
fractions will be adjusted in cash in an amount equal to the product of the
price of one share of HealthAxis Common Stock as determined in good faith by the
HealthAxis board of directors and the fractional interest.
Mandatory Conversion. All of the outstanding shares of HealthAxis
Series B Preferred Stock shall be converted into a number of shares of
HealthAxis Common Stock at the Conversion Price (as defined herein) upon the
earlier of: (i) the consummation of a underwritten public offering of the
HealthAxis Common Stock of HealthAxis at a net offering price per share that
represents a pre-offering market capitalization of not less than $200,000 and
aggregate proceeds (net of underwriting commissions and discounts) to HealthAxis
of not less than $25,000, or (ii) a Qualified Merger.
Voting Rights. In addition to the voting rights offered by the
applicable law, holders of the HealthAxis Series B Preferred Stock are entitled
to vote on all matters as to which holders of HealthAxis Common Stock are
entitled to vote. The holders of each share of HealthAxis Series B Preferred
Stock entitles the holder to the number of votes equal to the nearest whole
number of shares of HealthAxis Common Stock into which the holder's HealthAxis
Series B Preferred Stock is convertible under the holder's optional conversion
rights. Except as set forth below, the holders of HealthAxis Series B Preferred
Stock shall vote together with the holders of HealthAxis Common Stock and the
HealthAxis Series A and HealthAxis Series C Preferred Stock as one class.
The affirmative vote, in person or by proxy, of the holders of a
majority of the outstanding shares of the HealthAxis Series B Preferred Stock,
voting as a single class, shall be necessary for HealthAxis to: (a) authorize,
create, designate or establish any class or series of capital stock or other
security or other instrument convertible into or exchangeable for any security
Page 14 of 35 Pages
<PAGE>
ranking senior or on parity with the HealthAxis Series B Preferred Stock or
reclassify any shares of HealthAxis Common Stock into shares having any
preference or priority as to dividends or assets superior to any such preference
or priority of the HealthAxis Series B Preferred Stock; (b) in any other manner
amend or modify the powers, privileges, preferences, or rights or
qualifications, limitations or restrictions of the HealthAxis Series B Preferred
Stock as to materially adversely affect the holders of the HealthAxis Series B
Preferred Stock; (c) amend the Amended and Restated Articles of Incorporation or
Bylaws of HealthAxis so as to materially adversely affect the powers,
preferences or rights or qualifications, limitations or restrictions, of the
shares of HealthAxis Series B Preferred Stock; (d) consummate any consolidation
or merger of HealthAxis (other than any merger or consolidation resulting in the
holders of the capital stock of HealthAxis entitled to vote in the election of
directors holding a majority of the capital stock of the surviving entity that
is entitled to vote in the election of directors), or any person or entity
becoming the holder of a majority of the capital stock of HealthAxis entitled to
vote for the election of directors or any sale or disposition by HealthAxis of
all or substantially all of its assets; (e) increase or decrease the total
number of authorized shares of HealthAxis Series B Preferred Stock; (f) directly
or indirectly pay or declare any dividend or make any distribution upon, or
redeem or repurchase or otherwise acquire, any shares of capital stock or other
securities of HealthAxis (other than the repurchase of HealthAxis Common Stock
from employees upon termination or employment); (g) consummate any transaction
whereby HealthAxis shall obtain control, directly or indirectly, of an insurance
corporation; and (h) effect any change in or enter into any business other than
the business conducted by HealthAxis on the original issuance date.
Registration Rights. In connection with AOL's purchase of the
HealthAxis Series B Preferred Stock, HealthAxis and AOL entered into a
Registration Rights Agreement (the "AOL Registration Agreement"). The AOL
Registration Agreement sets forth the rights of AOL or any successor, assignee
or transferee (the "Investor") in connection with the public offering of
HealthAxis Common Stock acquired in connection with the conversion of HealthAxis
Series B Preferred Stock or other shares of HealthAxis Common Stock acquired
through the exercise of warrants granted to AOL.
At any time following the earlier of: (i) six months after HealthAxis'
initial public offering, or (ii) November 13, 2001, HealthAxis is required to
use its best efforts to effect up to two registrations under the Securities Act
of HealthAxis Common Stock held by Investor or issuable to Investor upon
exercise or exchange of any securities, including HealthAxis Series B Preferred
Stock ("Registrable Shares") upon receipt of written notice from the Investor.
HealthAxis shall not be obligated to use its best efforts to effect the
registration of Registrable Shares during any period in which any other
registration statement (other than on Form S-4 or S-8) pursuant to which
authorized but unissued HealthAxis Common Stock or treasury shares ("Primary
Shares") is to be sold has been filed or declared effective within the prior 90
days. Additionally, HealthAxis may delay the filing or effectiveness of any
registration statement related to the Registrable Shares for a period of 90 days
after the date of the Investor's demand if: (i) HealthAxis has plans to engage
within 60 days in a firm commitment underwritten public offering of Primary
Shares and the Investor would be afforded piggyback registration rights (as
described below) in connection with such offering; or (ii) HealthAxis gives the
Investor a certificate stating that in the good faith judgement of the
HealthAxis board of directors, it would be seriously detrimental to HealthAxis
for the registration statement to be filed and HealthAxis has not exercised this
right more than once in any 12 month period. If the managing underwriter advises
HealthAxis that the inclusion of all of the shares proposed to be included would
interfere with the successful marketing of the Primary Shares, then the shares
included in the registration will be as follows: (i) first, Registrable Shares
held by the Investor; (ii) second, Primary Shares; and (iii) third, HealthAxis
Common Stock which does not constitute Primary Shares or Registrable Shares
("Other Stock").
Page 15 of 35 Pages
<PAGE>
If HealthAxis intends to register Primary Shares, other than
Registrable Shares, under the Securities Act, it will promptly give written
notice to such effect to the Investor. Upon HealthAxis' receipt of written
notice from the Investor which must be received by HealthAxis within 30 days
after delivery of HealthAxis? notice to the Investor, HealthAxis will use its
best efforts to include those Registrable Shares in such registration. If the
managing underwriter advises HealthAxis that inclusions of all of the shares
proposed to be included would interfere with the successful marketing of the
Primary Shares, then the shares included in the registration will be as follows:
(i) first, Primary Shares; (ii) second, Registrable Shares held by the Investor;
and (iii) third, Other Shares.
Other. The HealthAxis Series B Preferred Stock is not subject to any
sinking fund or other similar provisions. The holders of HealthAxis Series B
Preferred Stock are entitled to certain preemptive rights, which are described
in the Stock Purchase Agreement related to the HealthAxis Series B Preferred
Stock.
Note G - HealthAxis.com, Inc. Series C Cumulative Convertible Preferred Stock
On March 30, 1999, HealthAxis issued 1,526,412 shares of HealthAxis
Series C Preferred Stock to a group of accredited investors at $5.77 per share
for an aggregate purchase price of $8,807, less issuance costs amounting to $300
and the value of HealthAxis warrants issued to certain investors valued at $788.
The terms of the HealthAxis Series C Preferred Stock are as follows:
Dividends. Holders of the HealthAxis Series C Preferred Stock will be
entitled to dividends accruing from the date of issue, if such dividends are
declared by the HealthAxis board of directors out of funds legally available
therefor. If any accrued dividends on the HealthAxis Series C Preferred Stock
have not been paid or set apart for payment, no dividends or other distributions
may be declared and paid or set apart for payment upon any HealthAxis Common
Stock, no par value per share of HealthAxis (the "HealthAxis Common Stock"), or
any series of preferred stock of HealthAxis (the "Preferred Stock") with a
dividend preference junior to the HealthAxis Series C Preferred Stock (the
"HealthAxis Series C Junior Stock"). In the event HealthAxis proposes to pay any
dividend upon the shares of HealthAxis Common Stock or any class of HealthAxis
Series C Junior Stock, dividends shall have been declared on the shares of
HealthAxis Series C Preferred Stock and a sum paid to the holders thereof or a
sum sufficient for the payment thereof shall have been set apart for such
payment, which sum equals a dividend per share of HealthAxis Series C Preferred
Stock which is not less than the proposed dividend per share to be paid on the
HealthAxis Common Stock or such other HealthAxis Series C Junior Stock, as the
case may be (determined, in the case of the HealthAxis Series C Preferred Stock,
on an as converted basis). HealthAxis does not anticipate paying any dividends
on its HealthAxis Series C Preferred Stock in the foreseeable future.
Page 16 of 35 Pages
<PAGE>
Liquidation. In the event of any distribution, liquidation or winding
up of the affairs of HealthAxis, whether voluntary or otherwise, after payment
or provisions for payment of the debts and other liabilities of HealthAxis and
payment of all amounts owed to the holders of the HealthAxis Series B Preferred
Stock, the holders of the HealthAxis Series C Preferred Stock shall be entitled
to receive, out of the assets of HealthAxis legally available for distribution
to its shareholders, an amount in cash equal to $5.77 ("HealthAxis Series C
Offering Price") per share for each share of HealthAxis Series C Preferred
Stock, plus an amount equal to all dividends accrued and unpaid, if any, on each
such share up to the date fixed for distribution, before any distribution may be
made to the holders of HealthAxis Common Stock, the HealthAxis Series A
Preferred Stock or HealthAxis Series C Junior Stock.
If after payment or provision for payment of the debts and other
liabilities of HealthAxis, the full amount due to holders of the HealthAxis
Series B Preferred Stock and distribution to the holders of the HealthAxis
Series C and the HealthAxis Series A Preferred Stock the full amount of their
preference, holders of the HealthAxis Series C Preferred Stock shall be entitled
to share on a pro rata basis the remaining assets of HealthAxis available for
distribution to shareholders with holders of the HealthAxis Common Stock and the
HealthAxis Series A and HealthAxis Series B Preferred Stock. The relative value
of a share of HealthAxis Series A, Series B and Series C Preferred Stock for
this purpose shall be determined on an "as converted" basis.
The consolidation or merger of HealthAxis with any corporation (other
than a transaction where holders of HealthAxis' voting capital stock hold a
majority of voting capital of the resulting entity), the sale of all or
substantially all of HealthAxis' assets, the acquisition by any person or entity
of a majority of the voting capital stock of HealthAxis, will be deemed a
liquidation or winding up of HealthAxis.
Redemption. The HealthAxis Series C Preferred Stock is not subject to
any mandatory redemption, sinking fund or other similar provisions.
Optional Conversion. Each share of HealthAxis Series C Preferred Stock
is convertible at any time at the option of the holder into a number of shares
of fully-paid and non-assessable shares of HealthAxis Common Stock equal to the
quotient obtained by dividing: (i) the HealthAxis Series C Offering Price per
share by; (ii) the HealthAxis Series C Conversion Price (as defined below). Each
share of HealthAxis Series C Preferred Stock shall be converted immediately upon
the consummation of an underwritten initial public offering of HealthAxis Common
Stock at a net offering price per share that represents a pre-offering market
capitalization of not less than $200,000 and aggregate proceeds (net of
underwriting commissions and discounts) to HealthAxis of not less than $25,000
(a "HealthAxis Series C Qualified Financing").
Page 17 of 35 Pages
<PAGE>
The HealthAxis Series C Conversion Price on the HealthAxis Series C
Preferred Stock shall be $5.77 per share subject to adjustment from time to time
in the event of: (i) the issuance of HealthAxis Common Stock as a dividend or
distribution on the HealthAxis Common Stock; (ii) the combination, subdivision
or reclassification of the HealthAxis Common Stock; (iii) the distribution to
all holders of HealthAxis Common Stock of evidences of HealthAxis' indebtedness
or assets (including securities, but excluding cash dividends or distributions
paid out of earned surplus); or (iv) the sale of HealthAxis Common Stock at a
price per share, or the issuance of options, warrants or convertible securities
with an exercise or conversion price per share, less than the then HealthAxis
Series C Conversion Price, except for Excluded Shares. No fractional shares will
be issued upon conversion, but any fractions will be adjusted in cash on the
basis of the then current market price of the HealthAxis Common Stock. Payment
of accumulated and unpaid dividends will be made upon conversion to the extent
of legally available funds as prescribed by statute.
Excluded Stock means: (i) up to 3,500,000 shares of HealthAxis Common
Stock issued to employees, directors and officers of and consultants to
HealthAxis pursuant to agreements approved by the HealthAxis board of directors;
provided that, any shares of HealthAxis Common Stock, options or warrants issued
after the date of filing of the Certificate of Designation for the HealthAxis
Series C Preferred Stock must be issued at a price of not less than $4.00; (ii)
shares of HealthAxis Common Stock issued upon conversion of any series of
Preferred Stock; (iii) shares of HealthAxis Common Stock issued by HealthAxis as
a stock dividend or upon any subdivision, split-up or combination of shares of
HealthAxis Common Stock; (iv) shares of HealthAxis Common Stock issued as a
stock dividend or stock split or upon any subdivision, split-up or combination
of shares of HealthAxis Common Stock; or (v) shares of HealthAxis Common Stock
issued pursuant to the market price protection provisions of the Stock Purchase
Agreement related to the HealthAxis Series C Preferred Stock.
Mandatory Conversion. All of the outstanding shares of HealthAxis
Series C Preferred Stock will be converted into a number of shares of HealthAxis
Common Stock at the Conversion Price upon the earlier of: (i) the consummation
of a underwritten public offering of the HealthAxis Common Stock of HealthAxis
at a net offering price per share that represents a pre-offering market
capitalization of not less than $200,000 and aggregate proceeds (net of
underwriting commissions and discounts) to HealthAxis of not less than $25,000
or (ii) a Qualified Merger. The term "Qualified Merger" shall mean an upstream
merger of HealthAxis with PAMCO or the merger of HealthAxis with a wholly-owned
subsidiary of PAMCO pursuant to which HealthAxis shall be the only operating
subsidiary of PAMCO and PAMCO's only operations shall be within HealthAxis upon
the following conditions:
(i) the merger is approved, in addition to such vote as may
otherwise be required by applicable law, by a majority vote of holders of the
HealthAxis Series B Preferred Stock and HealthAxis Series C Preferred Stock;
Page 18 of 35 Pages
<PAGE>
(ii) HealthAxis receives a fairness opinion from an investment
banking firm approved by a majority of the holders of the outstanding shares of
the HealthAxis Series B Preferred Stock and HealthAxis Series C Preferred Stock,
which approval shall not be unreasonably withheld, indicating that the merger is
fair to the stockholders of HealthAxis, other than PAMCO and its subsidiaries,
from a financial point of view;
(iii) the securities to be issued to holders of the Preferred
Stock upon the completion of the merger shall be registered with the Securities
and Exchange Commission pursuant to the Securities Act of 1933, as amended
("Securities Act"), freely tradable and listed on a national securities exchange
or quoted on the NASDAQ Stock Market; and
(iv) the resulting entity has a market capitalization of at
least $200,000.
Voting Rights. In addition to the voting rights offered by the
applicable law, holders of the HealthAxis Series C Preferred Stock are entitled
to vote on all matters as to which holders of HealthAxis Common Stock are
entitled to vote. The holders of each share of HealthAxis Series C Preferred
Stock entitles the holder to the number of votes equal to the nearest whole
number of shares of HealthAxis Common Stock into which the holder's HealthAxis
Series C Preferred Stock is convertible under the holder's optional conversion
rights. Except as set forth below, the holders of HealthAxis Series C Preferred
Stock shall vote together with the holders of HealthAxis Common Stock and the
HealthAxis Series A and HealthAxis Series B Preferred Stock as one class.
The affirmative vote, in person or by proxy, of the holders of a
majority of the outstanding shares of the HealthAxis Series C Preferred Stock,
voting as a single class, shall be necessary for HealthAxis to: (a) amend,
repeal or modify any provisions of, or add any provision to, HealthAxis' Amended
and Restated Articles of Incorporation if such action would alter or change the
rights, preferences, privileges or powers of, or the restrictions provided for
the benefit of, the HealthAxis Series C Preferred Stock so as to affect the
HealthAxis Series C Preferred Stock adversely; (b) authorize, create or issue
any additional shares of any class or series of Preferred Stock senior to or on
parity with the HealthAxis Series C Preferred Stock, or authorize, create or
issue shares of any class or series of stock or any bonds, debentures, notes or
other obligations convertible into or exchangeable for, or having optional
rights to purchase, any shares of stock senior to the HealthAxis Series C
Preferred Stock or Parity Stock; (c) reclassify the shares of HealthAxis Common
Stock or any other shares of any class or series of Preferred Stock into shares
of Preferred Stock senior to or on parity with the HealthAxis Series C Preferred
Stock; (d) increase the number of shares of HealthAxis Series C Preferred Stock;
(e) consummate any corporate transaction; (f) directly or indirectly pay or
declare any dividend or make any distribution upon, or redeem, retire or
repurchase or otherwise acquire, any shares of capital stock or other securities
of HealthAxis other than the HealthAxis Series B Preferred Stock (other than the
repurchase of HealthAxis Common Stock from employees upon termination or
employment); or (g) consummate any transaction whereby HealthAxis shall obtain
control, directly or indirectly, of an insurance corporation.
The Stock Purchase Agreement related to the HealthAxis Series C
Preferred Stock provides that as long as holders of the HealthAxis Series C
Preferred Stock hold or have the right to acquire upon conversion at least 10%
Page 19 of 35 Pages
<PAGE>
of the outstanding equity securities of HealthAxis, a majority of such
HealthAxis Series C holders shall be entitled to nominate for election and
HealthAxis will use its best efforts to support for election to the HealthAxis
board of directors a nominee for director selected by the holders of the
HealthAxis Series C Preferred Stock. If the board of directors of HealthAxis is
increased to between eight and 14 members, the right of holders of the
HealthAxis Series C Preferred Stock to nominate one director shall be increased
to the right to elect two directors and if the board is increased to 15 or more
members holders of the HealthAxis Series C Preferred Stock shall have the right
to nominate three directors, subject to the limitations set forth in the Stock
Purchase Agreement. In addition, PAMCO agreed to vote and to cause its
subsidiaries to vote all shares of HealthAxis owned by them in favor of the
HealthAxis Series C nominees.
Registration Rights. When HealthAxis proposes to register any shares of
HealthAxis Common Stock from authorized but unissued common shares or treasury
shares under the Securities Act (other than on a Form S-4 or a Form S-8),
HealthAxis is required to give notice to the holders of HealthAxis Series C
Preferred Stock and the holders of HealthAxis Common Stock acquired upon the
conversion of HealthAxis Series C Preferred Stock of the proposed registration
and the right to include their shares of HealthAxis Common Stock received upon
the conversion of the HealthAxis Series C Preferred Stock ("HealthAxis Series C
Conversion Shares") in such registration (a "Piggyback Registration"), subject
to certain conditions including the right of the underwriter of such offering to
limit the number of HealthAxis Series C Conversion Shares sold by the holders if
the underwriter advised HealthAxis and such holders in writing that the number
of HealthAxis Series C Conversion Shares required to be included by such holders
would interfere with the successful marketing of the shares offered. Such
Piggyback Registration rights are subject to the priority rights granted to
HealthPlan Services, Inc. ("HPS"), holders of the HealthAxis Series B Preferred
Stock and certain warrant holders. Subject to rights granted to HPS, holders of
the HealthAxis Series B Preferred Stock and certain warrant holders, the holders
of at least 25% of the then outstanding shares of HealthAxis Series C Preferred
Stock may also require HealthAxis to file up to two registration statements
("demand registrations") under the Securities Act with respect to the HealthAxis
Common Stock acquired upon the conversion of the HealthAxis Series C Preferred
Stock held by such holders desiring to participate, subject to certain
conditions. Such demand may not be made earlier than: (i) 12 months from the
closing of the offering of the HealthAxis Series C Preferred Stock or (ii) six
months after HealthAxis' initial public offering. HealthAxis is required to pay
all registration expenses (as defined in the Registration Rights Agreement to be
executed in connection with this transaction), other than any underwriting
discounts and commissions for any underwriter or broker-dealer acting on behalf
of the holders of the HealthAxis Series C Conversion Shares.
Other. The holders of HealthAxis Series C Preferred Stock are not
entitled to any preemptive rights. Shares of HealthAxis Series C Preferred Stock
offered hereby and the shares of the HealthAxis Common Stock issuable upon
conversion will, when issued, be validly issued, fully paid and non-assessable
shares of HealthAxis.
In connection with the sale of the HealthAxis Series C Preferred Stock,
HealthAxis amended the rights and preferences of HealthAxis Series A Preferred
Stock and HealthAxis Series B Preferred Stock to, among other things, provide
for the preference of HealthAxis Series C Preferred Stock over the HealthAxis
Series A Preferred Stock, to clarify the priorities of the Series A, B and C
Preferred Stock in the event of a liquidation, to delete the dividend currently
Page 20 of 35 Pages
<PAGE>
payable on the HealthAxis Series A and B Preferred Stock, to delete the optional
redemption provision related to the HealthAxis Series A Preferred Stock, to
revise the optional and mandatory conversion provisions applicable to the
HealthAxis Series A and B Preferred Stock and to revise the definition of
excluded Shares applicable to the HealthAxis Series A Preferred Stock.
Note H - Reinsurance and Deferred Acquisition Cost Impact on Benefits and
Expenses
Accident and health policy benefits, commissions and other operating
expenses are net of the following ceded reinsurance and deferred acquisition
cost amounts:
3 Months Ended March 31,
1999 1998
--------- ----------
Accident and health benefits
Gross before reinsurance ceded $ 20,894 $ 19,259
Less reinsurance ceded 20,489 7,163
Net of reinsurance ---------- ----------
$ 405 $ 12,096
========== ==========
Commissions
Gross before reinsurance ceded $ 4,052 $ 7,587
Less reinsurance ceded 3,608 3,915
Less deferred acquisition costs 187 880
---------- ----------
$ 257 $ 2,792
========== ==========
Other operating expenses
Gross before reinsurance ceded $ 4,865 $ 7,406
Less reinsurance ceded 15 1,729
Less deferred acquisition costs 39 416
Net ---------- ---------
$ 4,811 $ 5,261
========== =========
Effective December 31, 1998, the Company and PILIC signed an agreement
to reinsure 100% of its group medical and group life inforce business and sell
the Company's group medical marketing, sales distribution rights and all of the
outstanding capital stock of PALHIC to Central Reserve Life Insurance Company
("CRLC") (the "CRLC Agreement").
Page 21 of 35 Pages
<PAGE>
Under the CRLC Agreement, PALHIC reinsured 100% of its business to
PILIC, which in turn reinsured through a 100% coinsurance agreement, all of the
Company's group medical and group life business to Reassurance Company of
Hannover ("RCH"). In addition, PILIC sold all of the outstanding shares of
PALHIC and NIA to CRLC for an amount equal to PALHIC's capital and surplus. The
Company transferred all rights and control regarding the Company's licensed
insurance agents and entered into a non-compete and non-solicitation agreements
with CRLC regarding the Company's licensed insurance agents with respect to the
future sale of health insurance products for a three year period.
Effective December 31, 1998 PILIC entered into a coinsurance agreement
with RCH whereby PILIC received a $10,000 ceding commission which consisted of a
$5,000 non-refundable payment and a $5,000 payment contingent upon RCH's earning
at least $10,000 in future profits from the ceded inforce business, plus 12%
interest (the "guaranteed amount"). PILIC recognized the $10 million as ceding
commission revenue net of transaction costs of $417 and PAMCO recognized a $5
million ceding commission liability because of the negative financial history of
the business. As a result of the transaction, PILIC wrote-off unamortized
deferred acquisition costs and restructuring costs aggregating $4.2 million.
If RCH fails to earn the guaranteed amount within five years of the
date of the closing of the CRLC transaction, PAMCO must repay RCH the lesser of
the guaranteed amount less RCH's actual profits on the inforce business, or
$5,000, plus 12% interest. In the unlikely event that future profits exceed the
guaranteed amount, then PILIC is entitled to receive an additional payment from
RCH equal to two-thirds of the policy fees collected during 1999 and one-third
of the policy fees collected during 2000.
As security for PAMCO's guarantee, PAMCO executed a security agreement
in favor of RCH secured by the stock of PILIC. This agreement provides that RCH
will take ownership of PILIC if the Company defaults on its guarantee to RCH.
PAMCO provides various affirmative covenants regarding corporate existence;
compliance with laws; furnishing various notices to RCH; inspection and audit
rights and insurance coverage. Additionally, PAMCO provides certain negative
covenants with regard to selling, assigning, leasing or otherwise disposing of
PAMCO or PILIC assets; entering into agreements materially and adversely
effecting PAMCO's or PILIC's ability to carry on business; entering into an
agreement materially and adversely effecting PAMCO or PILIC ability to perform
obligations under the Guaranty, the reinsurance agreement with RCH, the Stock
Purchase Agreement and other related agreements. There also exist various
provisions regarding PAMCO or PILIC incurring or creating indebtedness or
declaring dividends.
Under the CRLC Agreement, PILIC has the right to assume new business
written by PILIC's agents for five years after the effective date of the CRLC
Agreement. PILIC may assume up to 20% of the new business written by PILIC's
agents during 1999 and up to 50% for the remaining four years via a new quota
share reinsurance agreement with PALHIC. PILIC may also assume 50% of the new
business sold through HealthAxis and directly underwritten by PALHIC commencing
January 1, 1999 via a new quota share reinsurance agreement with PALHIC for a
period of 3 years. PILIC does not anticipate assuming any business under these
agreements in 1999.
Page 22 of 35 Pages
<PAGE>
Reinsurance does not relieve the Company of its primary obligation to
its policyholders and varies according to the age of the insured, type of risk
and type of policy. Retention amounts for life insurance range up to $50 of
coverage per individual life and for health insurance up to $85 per individual.
During 1998, the Company had Quota Share Reinsurance and Excess of Loss
Reinsurance arrangements on its group medical insurance with a group of
reinsurers which were terminated by the Company effective December 31, 1998 in
connection with the reinsurance and other agreements with RCH and CRLC.
Under the terms of Quota Share Reinsurance Agreements, the Company
ceded 47.5% of the liability on its accident and health insurance business. The
Company received ceding commissions of: 45.5% on all first year business, and
25.5% or 30.5% on renewal business, depending on product, in 1998. The combined
ceding commissions amounted to approximately 36.9% of ceded earned premium for
12 months ended December 31, 1998.
The Company's medical quota share and excess reinsurance agreements
with Swiss Re were terminated effective December 31, 1997. Swiss Re's obligation
to assume its proportionate share of medical paid losses incurred prior to
January 1, 1998 remains in effect. The amount of reinsurance recoveries from
Swiss Re is currently in dispute. Although the amount of loss, if any, cannot be
determined with any certainty at this time, the Company believes that such
amounts are due and collectible and has asserted its rights under the
reinsurance contract.
During 1999 the Company has and will continue to cede 100% of the Company's
small group and managed care business to RCH. During the first quarter the
Company decided to cease its participation via assumption reinsurance of stop
loss business administered by MMC. The Company has also determined not to assume
any business from CRLC.
In addition, the Company generally assumes 30% (up to $150 per
individual) of the liability on its limited self-funded accident and health
business, which consists generally of policies issued to limit the claims
expenses of employers that self-insure group medical benefits with respect to
any individual employee and in the aggregate.
Page 23 of 35 Pages
<PAGE>
Note I - Settlement Agreement with HPS
Sale of Montgomery Management: Effective March 31, 1999 the Company
sold its remaining 20% of MMC common stock to HPS for a purchase price of
$1,500, payment of which was made by a set off of a like amount against future
service fees accounted for as a loan payable owed by the Company to HPS. The
Company recognized a $1,500 pre-tax gain on the sale.
In a previous agreement, in February 1998 the Company sold for $4,000
49% of MMC common stock along with a warrant to purchase an additional 31% of
MMC's common stock for one dollar. Immediately prior to the sale MMC declared a
dividend payable to its parent PILIC equal to its total equity. During the
fourth quarter of 1998 the buyer exercised the warrant to purchase the
additional 31% of MMC's Common Stock for $8. The Company recognized a $4,000
pre-tax gain on the sale of MMC in 1998. Effective with the sale in 1998 the
Company includes MMC in the Company's consolidated financial statements on the
equity basis.
Commitment to pay outstanding HPS service fees to HPS: In conjunction
with the sale of MMC described above, PAMCO entered into a settlement agreement
to resolve a number of disputes that have arisen between the Company and HPS
relative to HPS' performance of administrative services under the HPS
Outsourcing Agreement of the now ceded block of Provident Health business. The
companies agreed to settle all differences and claims related to the HPS
Outsourcing Agreement and certain actions taken by HealthAxis regarding
HealthAxis' obligations under certain agreements between the parties. Also in
accordance with the terms of the settlement agreement, HPS exercised a warrant
granted in 1998 in connection with the HPS E-Commerce Agreement, and purchased
100,000 shares of the common stock of PAMCO for a purchase price of $900. The
purchase price was paid by a setoff of a like amount against the service fees
owed by the Company to HPS. The remaining balance of the services fees owed to
the Company by HPS in the amount of $1,267 shall be paid by the Company to HPS
on or before June 30, 1999, whereupon the Company's obligation to pay service
fees shall be terminated.
Note J - Subsequent Events
HealthAxis issuance of common stock: On May 11, 1999, HealthAxis
completed a private placement of 516,051 shares of HealthAxis Common Stock to a
group of accredited investors at $12 per share for an aggregate purchase price
of $6,193, less issuance costs estimated to be approximately $100. The net
proceeds of approximately $6,100, will be used for working capital and other
general corporate purposes, including marketing expenses, web site enhancements,
salary expenses and advertising and promotional expenses of HealthAxis.
Page 24 of 35 Pages
<PAGE>
Investors purchasing HealthAxis Common Stock Offering (the "Offering")
were provided with registration rights described herein. When HealthAxis
proposes to register any shares of HealthAxis Common Stock from authorized but
unissued HealthAxis common shares or treasury shares under the Securities Act
(other than on a Form S-4 or a Form S-8), HealthAxis is required to give notice
to the holders of HealthAxis Common Stock purchasing in the Offering, the
proposed registration and the right to include their shares of Common Stock in
such registration (a "Piggyback Registration"), subject to certain conditions
including the right of the underwriter of such offering to limit the number of
HealthAxis Common Stock sold by the holders if the underwriter advised
HealthAxis and such holders in writing that the number of HealthAxis Common
Stock required to be included by such holders would interfere with the
successful marketing of the shares offered. Such Piggyback Registration rights
are subject to the priority rights granted to HealthPlan Services, Inc. ("HPS"),
holders of HealthAxis Series B Preferred Stock and HealthAxis Series C Preferred
Stock and certain HealthAxis warrant holders. Subject to rights granted to HPS,
holders HealthAxis Series B Preferred Stock and HealthAxis Series C Preferred
Stock and certain HealthAxis warrant holders, the holders of at least 2% of the
then outstanding shares of HealthAxis Common Stock purchased in the Offering may
also require HealthAxis to file up to two registration statements ("demand
registrations") under the Securities Act with respect to HealthAxis Common Stock
acquired in the Offering held by such holders desiring to participate, subject
to certain conditions. Such demand may not be made earlier than: (i) 12 months
from the closing of the offering of the HealthAxis Series C Preferred Stock or
(ii) six months after the HealthAxis' initial public offering. HealthAxis is
required to pay all registration expenses (as defined in the Registration Rights
Agreement to be executed in connection with this transaction), other than any
underwriting discounts and commissions for any underwriter or broker-dealer
acting on behalf of the holders of HealthAxis Common Stock.
As of May 11, 1999, 16,738,811 shares of HealthAxis common stock were
issued and outstanding. Of this amount, 13,807,395 or approximately 83% were
owned by PAMCO, 2,365,365 or approximately 14% were owned by HPS and the
remaining approximate 3% were owned by a group of accredited investors and
HealthAxis directors and employees. As a result of this issuance, the minority
interest in HealthAxis will represent the approximate 17% of HealthAxis' common
equity that is not owned by PAMCO.
Stock Purchase Agreement to buy-back HealthAxis common stock from HPS:
On May 13, 1999 PAMCO entered into a Stock Purchase Agreement for the purchase
of 1,415,000 shares of HealthAxis no par value common stock from HPS for $7,040
to close on or before June 30, 1999. If PAMCO does not close on or before June
30, 1999 then PAMCO will pay HPS a late fee of $100 to extend closing until July
30, 1999. If a closing does not occur by July 30, 1999, the purchase price per
share shall increase by 8 1/2% per month until closing, of which all events must
occur on or before November 1, 1999.
Note K - Investment Considerations
In analyzing whether to make, or continue, an investment in the
Company, investors should consider, among other factors, certain investment
considerations more particularly described in the Company's Annual Report on
Form 10-K/A for the year ended December 31, 1998, a copy of which can be
obtained from the Company.
Page 25 of 35 Pages
<PAGE>
Note L - Forward-looking Statements
The information contained in the Quarterly Report on form 10-Q for the
quarter ended March 31, 1999 contains forward-looking statements (as such term
is defined under Section 21E of the Securities Exchange Act of 1934 and the
regulations thereunder), including without limitation, statements as to trends,
management's beliefs, expectations or opinions, which are based upon a number of
assumptions concerning future conditions that ultimately may prove to be
inaccurate.
Such forward-looking statements are subject to risks and uncertainties
and may be affected by various factors, which may cause actual results to differ
materially from those in the forward-looking statements. Certain of these risks,
uncertainties and other factors are discussed in the Company's Annual Report on
Form on 10-K/A for the year ended December 31, 1998.
Page 26 of 35 Pages
<PAGE>
Item 2. Management's Discussion and Analysis of Financial Condition and Results
of Operations.
Results of Operations
Net (loss) applicable to common stock was ($3.0) million or ($.26) per
diluted share for the three months ended March 31, 1999 ("1999") compared to net
income of $2.6 million or $0.22 per diluted share for three months ended March
31, 1998 ("1998"). The Company's 1999 results included a $1.5 million gain on
the sale of the Company's remaining 20% of MMC's common stock, whereas 1998
results included a $4.0 million gain on the sale of 80% of MMC's common stock
described in Note I.
During 1998 the Company revised its strategy to focus predominately on
HealthAxis, the Company's E-Commerce insurance marketing subsidiary. In early
1998 the Company determined that the Internet provided the opportunity to sell
health and life insurance directly to consumers thereby reaching individuals at
a cost potentially lower than traditional agency marketing channels. In light of
the losses experienced in the Company's small group and managed care products
and the need to devote capital and focus to HealthAxis, the Company entered into
various agreements to sell PILIC's subsidiaries (MMC, PALHIC and NIA) and cede
100% of the group medical and group life business during 1998.
On December 31, 1998 the Company executed a series of transactions
whereby PALHIC reinsured 100% of its business to PILIC, which in turn reinsured
via a 100% co-insurance reinsurance agreement all of the Company's group medical
and group life business to the RCH. In addition PILIC sold PALHIC and NIA to
CRLC, transferred all rights and control regarding the Company's agents and
entered into non-compete and non-solicitation agreements regarding the Company's
agents with respect to the future sale of health insurance products by agents
for a 3-year period.
Accident and health gross premium was $25.5 million for 1999 compared
to $28.7 million for 1998. Accident and health ceded premium was $25.0 million
for 1999 compared to $11.7 million for 1998. As a result of the transactions
with CRLC and RCH, the Company has experienced a substantial decline in net
earned premium in comparison to 1998 and prior years. The Company has and will
continue to cede 100% of the Company's small group and managed care business to
RCH. During the first quarter the Company decided to cease its participation via
assumption reinsurance of stop loss business administered by MMC. The Company
has also determined not to assume any business from CRLC. As a consequence of
these decisions, the Company's net health premium is expected to decline to a
nominal amount by the end of 1999.
Life and annuity premium, gross of $1.7 million for 1999 declined from
$2.5 million for 1998 due to reduced pre-need premium. Life and annuity
reinsurance ceded of $0.5 million increased from $0.1 million in 1998 as a
result of the transactions with CRLC and RCH.
Realized gain on the sale of subsidiaries of $1.5 million in 1999 and
$4.0 million in 1998 consisted of realized gains on the sale of 20% and 80%,
respectively of MMC to HPS as described in Note I.
Page 27 of 35 Pages
<PAGE>
Accident and health policy benefits ratio net of reinsurance increased
to 84% for 1999 compared to 71.3% for 1998 as a result of a change in the mix of
business away from one life group medical to stop loss business. Although the
Company believes policy claim liabilities for small group and managed care
business as of December 31, 1998 are adequate, greater than anticipated claim
experience could have a materially adverse impact on the Company's financial
position and results of operations.
Commissions, net of ceding allowance and deferred acquisition costs of
$0.3 million for 1999 decreased from $2.8 million in 1998 as a result of the
transactions with CRLC and RCH.
Other operating expenses, net of ceding allowance and deferred
acquisition costs of $4.8 million for 1999 decreased from $5.3 million in 1998
primarily due to lower expenses in the Company's insurance operations offset by
higher expenses associated with HealthAxis. The Company anticipates that
expenses will increase during 1999 as HealthAxis executes its business plan.
Amortization of deferred policy acquisition costs of $0.1 million for
1999 related to the Company's life business whereas the $0.2 in 1998 included
both managed care and life amortization of deferred policy acquisition costs.
Liquidity and Capital Resources
A major objective of the Company is to maintain sufficient liquidity to
fund growth, fulfill statutory requirements and meet all cash requirements with
cash and short term equivalents plus funds generated from operating cash flow.
The primary sources of cash for insurance operations are premiums,
investment income and investment sales and maturities. The primary uses of cash
for insurance operations are benefit payments to insureds, operating costs
including policy acquisition costs and investment purchases.
During 1998, the Company's liquidity requirements were primarily
created and met by PILIC and PALHIC, along with the sale proceeds of MMC,
PALHIC, and NIA. The primary sources of cash for HealthAxis were the issuance of
debt and equity securities to outside parties and to PILIC. The primary uses of
cash for HealthAxis were operating costs and payments to AOL, Lycos and CNet.
During 1999, the Company's liquidity requirements will be primarily
created and met by HealthAxis and PAMCO through their issuance of debt and
equity securities by the Company to outside parties. PILIC's liquidity
requirements will be met by the sale of short and intermediate term interest
bearing marketable securities and, to a lesser degree, individual life premiums,
investment income and administrative fees. The primary uses of cash for
HealthAxis will continue to be operating costs and payments to AOL, Lycos, Snap
and CNet, while PILIC's primary uses will be claim payments and associated
general expenses related to the 1998 claim run-off, which have been established
as claim reserves.
Page 28 of 35 Pages
<PAGE>
Cash and investments carried at market value at March 31, 1999 amounted
to $47.6 million. This included $30.8 million of bonds issued by the U.S.
Government, government agencies, public utilities and other corporations, $1.1
million invested in policy loans and other invested assets and $15.6 million in
cash and cash equivalents. Bonds are investment grade securities with fixed
incomes ranging in maturity from one to 30 years. The gross average yield on
fixed income bonds as of March 31, 1999 and December 31, 1998 was 6.9% and 6.3%,
respectively. The Company's investment policy is to buy medium term U.S.
government direct and agency bonds. All bonds are considered to be "available
for sale". The Company and its subsidiaries do not invest in high-yield debt
instruments, defined as securities below investment grade with interest rates or
yields significantly above market rates nor does the Company invest in
derivatives or hedging in financial instruments.
Net cash used in operating activities of $21.9 million in 1999 reflects
negative cash flow from the Company's claim payments and associated general
expenses related to the 1998 claim run-off of group medical business, individual
life lines, and the impact of HealthAxis' general expenses and payments to AOL.
During 1999 HealthAxis made the final payment of $1.5 million to AOL
under the initial term of Second Amendment to the Amended and Restated
Interactive Marketing Agreement with AOL. During 1999, $1.4 million of
amortization of prepaid interactive marketing expense as described in Note D has
been included in depreciation and amortization.
Amounts due from reinsurer increased primarily due to the 100% cession
of group medical claims effective January 1, 1999 as described in Note H.
In connection with the Company's outsourcing to HPS, the Company
received premiums, net of commissions, HPS fees and certain out of pocket
expenses monthly on or before the 15th of following month. The $6.8 million
change in amounts due from third party administrator represented December 1998's
net cash settlement collected from HPS in January 1999.
Change in other assets, current and deferred income taxes and other
liabilities of ($1.4) million related primarily to the payment of costs
associated with the CRLC transactions.
Future policy benefits and claims of $9.3 million in the current year
in comparison to the prior year due to the 1998 claim run-off of group medical
business.
Non cash repayment of notes payable represents $1.5 million of
consideration for the Company's sale of MMC common stock and for HPS' exercise
of its warrant obtained in 1998 in connection with the HPS E-Commerce Agreement
to purchase 100,000 shares of PAMCO common stock for $900 as described in Note I
of the Notes to Financial Statements.
The Company anticipates that it will fund surrenders and benefit
payments along with other operating expenses by a significantly reduced level of
premiums together with scheduled investment maturities and the liquidation of
short and intermediate-term investments.
Page 29 of 35 Pages
<PAGE>
The statutory capital and surplus of PILIC was $4.3 million at March
31, 1999, which is $2.1 million below Company Action Level RBC as calculated at
December 31, 1998. The statutory capital and surplus of PILIC, was $4.8 million
at December 31, 1998. At December 31, 1998, PILIC calculated its "Risk Based
Capital" utilizing a formula required by the National Association of Insurance
Commissioners. The results of this computation indicate that PILIC's adjusted
capital of $5.3 million exceeded Regulatory Action Level but was below Company
Action Level. PILIC's year end 1998 RBC calculation included approximately $4.8
million of RBC related to PILIC's one life group health and group life business
100% ceded to RCH effective January 1, 1999. The RBC formula estimates RBC based
on a variety of historical data including 1998 net earned premium. The effects
of the reinsurance agreement between PILIC and RCH on PILIC's RBC calculation
will not be realized until 1999. In concept, Risk Based Capital standards are
designed to measure the acceptable amounts of capital an insurer should have
based on inherent and specific risks of the insurers business. This formula is a
primary measurement as to the adequacy of total capital and surplus of life
insurance companies. Since PILIC failed to meet its RBC requirement as of
December 31, 1998 it may be subject to regulatory action. Insurers failing to
meet their RBC requirement may be subject to scrutiny by its domiciled insurance
department and other insurance departments, which the insurer does business in,
and, ultimately, rehabilitation or liquidation. Several Departments of Insurance
have requested that PILIC submit a Risk Based Capital Plan ("RBC Plan") because
PILIC's adjusted capital of $5.3 million was below Company Action Level as of
December 31, 1998. The goal of PILIC's RBC Plan is for PILIC's adjusted
statutory capital and surplus level to exceed PILIC's Company Action Level RBC.
PILIC has submitted its RBC Plan and is working on refining and executing its
RBC Plan to achieve its objective.
Administrative rules and legal restrictions of state insurance
departments presently prevent payment of dividends by PILIC to PAMCO without
regulatory approval. Payment of dividends paid by HealthAxis to PAMCO is subject
to restrictions set for in the Certificate of Designation related to HealthAxis
Series A, B and C Convertible Preferred Stock. PAMCO and PILIC are also
restricted from paying dividends as described in Note H. PAMCO, PILIC and
HealthAxis do not anticipate paying cash dividends in the foreseeable future.
Impact of Inflation
Inflation increases the need for insurance. Many policyholders who once
had adequate insurance programs increase their life insurance coverage to
provide the same relative financial benefits and protection. The effect of
inflation on medical costs leads to accident and health policies with higher
benefits. Thus, inflation has increased the need for life and accident and
health products.
The higher interest rates which have traditionally accompanied
inflation also affect the Company's investment operation. The market value of
the Company's fixed rate long-term investments decreases as interest rates
increase.
Page 30 of 35 Pages
<PAGE>
Inflation has significantly increased the cost of health care. The
adequacy of premium rates in relation to the level of health claims is
constantly monitored and, where appropriate, premium rates on such policies,
when appropriate, are increased as policy benefits increase. Failure to make
such increases commensurate with health care cost increases may result in a loss
from health insurance operations.
The Company's pre-need products include periodic adjustments to the
face amount of the policy for increases in the consumer price index.
HealthAxis Expenditures and Commitments
HealthAxis has entered into an Interactive Marketing Agreement with AOL
and promotional agreements with Cnet, SNAP and Lycos. In connection with these
agreements the Company has paid $13.7 million in cash and warrants as of March
31, 1999 and is required to pay additional amounts as described in Company's
Annual Report on Form 10-K/A for the year ended December 31, 1998 as described
in Notes F, G, H and AA to the Company's Consolidated Financial Statements.
In 1998, HealthAxis obtained $13.9 million in funding consisting of (i)
a $750,000 fee paid by HPS in March 1998 in consideration of HPS being granted
the right to administer certain of the health insurance business written by
PILIC and PALHIC; (ii) a $5.0 million loan together with accrued interest from
HPS to HealthAxis in May 1998, which was converted in September 1998 into
2,365,365 shares of HealthAxis common stock; (iii) the purchase by PILIC of $2.4
million of Series A Preferred Stock of HealthAxis in September 1998; (iv) the
purchase by PAMCO of 682,395 shares of common stock of HealthAxis in November
1998 for $3.0 million; and (v) the purchase by AOL of $2.75 million of Series B
Preferred Stock of HealthAxis in November, 1998.
In 1999, HealthAxis completed an offering of approximately $8,800 of
HealthAxis Series C Preferred Stock (described in Note G) and approximately
$6,200 of HealthAxis common stock (described in Note J) solely to "accredited
investors" (as defined in Rule 501 of Regulation D under the Securities Act) of
which $8,800 was received on March 30, 1999 and $6,200 was received on May 11,
1999. The net proceeds of both offerings are anticipated to be used to fund
amounts due under the Company's distribution agreements with AOL, Lycos, Snap
and CNet through the end of 1999 and the balance will be used by HealthAxis for
its working capital and other general purposes. The Company believes that the
net proceeds together with its current cash and cash equivalents will be
sufficient to fund current operations and amounts due to AOL, Cnet, Snap and
Lycos during 1999. However, subsequent equity or debt financings will be
necessary to enable the Company to continue to implement its current business
strategy.
Page 31 of 35 Pages
<PAGE>
Year 2000 compliance
Year 2000 issues are the result of computer programs being written
using two digits rather than four to define the applicable year. In other words,
date-sensitive software may recognize a date using "00" as the year 1900 rather
than the Year 2000. This could result in system failures or miscalculations
causing disruptions in operations, including, among other things, a temporary
inability to process transactions, send invoices, or engage in similar normal
business activities.
The Company utilizes various computer software programs, operating
systems and vendors whose software programs and communication links ("Computer
Systems") are used in the Company's insurance and HealthAxis e-commerce
businesses. For the Company's insurance business these Computer Systems include
health insurance administration provided by HPS, life insurance administration,
health claims discount repricing provided by First Health Group along with
financial accounting and actuarial systems. For HealthAxis, these Computer
Systems include the www.healthaxis.com web site, links to AOL along with the AOL
online network, HPS, First Health Group, along with HealthAxis' data warehouse.
In 1999, the Company expects to have links to CNet, Lycos, Snap.com as well as
Carrier Partners who will offer their products through the HealthAxis web site.
To the extent that the Company's Computer Systems contain source codes that are
unable to appropriately interpret the Year 2000 then some level of modification,
or even replacement of such applications may be necessary. The result of these
Year 2000 issues may, if not corrected, have a significant negative impact on
Company's business.
The Company has begun an assessment of the Company's Year 2000
readiness and has identified applications owned by the Company, which are not
Year 2000 compliant. Furthermore, the Company believes that the Computer Systems
of many of its vendors or Carrier Partners that provide critical services to the
Company are not currently Year 2000 compliant.
To date, the Company has experienced very few Year 2000 problems with
those problems centering on life administration processing. The cost of
programming changes as of March 31, 1999 was less than $20,000. The Company is
in the process of evaluating alternatives to its life administration Year 2000
issues including the modification of the life administration system at a cost
yet to be estimated or the effective replacement of the system via outsourcing
of the life system at an estimated incremental annual cost of approximately
$300,000 per year and a one time conversion cost of approximately $300,000. The
Company anticipates selecting a Year 2000 plan to address its life
administration Year 2000 issues by the end of the second quarter of 1999. To
date, the Company has replaced its general ledger and accounts payable
accounting systems, which were not Year 2000 compliant, in January 1998 at a
cost of approximately $180,000.
The Company intends to conduct an analysis to determine whether its
vendors, Carrier Partners, Distribution Partners, and other business partners
(in so far as they are material to the Company's business) have any Year 2000
issues. As part of this process, the Company intends to request its vendors
provide them with information regarding their progress in identifying and
addressing their Year 2000 problems. Based on information reported in quarterly
SEC filings, AOL and HPS anticipate being Year 2000 compliant no later than
December 31, 1999 and June 30, 1999, respectively.
Page 32 of 35 Pages
<PAGE>
To date the Company has eliminated its health administration system by
outsourcing of the health administration and claims processing to HPS effective
February 1998 and assigned responsibility of the oversight of HPS' health
administration and claims processing along with the Company's former health
agent and underwriting computer systems to CRLC effective December 31, 1998.
In the event that the computer systems of the Company or any of the
Company's vendors Carrier Partners or other business partners fail or exhibit
significant problems as a result of Year 2000 processing the Company's service
to its customers could be disrupted for a significant amount of time and result
in significant lost income to the Company.
There are risks associated with the Company's Year 2000 exposure
relating to some external vendors with whom the Company depends on material
sales and service processing. Because the Company does not control these vendors
or their resources, the Company can provide no assurance that such vendors will
complete their respective Year 2000 solutions in time for the Company to fully
test system interfaces with them. Although the Company is coordinating its
efforts with vendors to minimize this impact of Year 2000 issues, the Company is
currently unable to predict the extent to which Year 2000 issues will affect its
operations, or the extent to which it would be vulnerable to the failure of its
vendors, Carrier Partners or other business partners to remediate any Year 2000
issues on a timely basis.
The Company has begun the process of developing a contingency plan to
address possible Year 2000 risks to its Computer Systems. There is no assurance
that the Company will successfully implement its contingency plan or make all of
its systems Year 2000 compliant. The Company does not currently have a
contingency plan in place in the event any third party in which it engages in
business is not Year 2000 compliant.
Page 33 of 35 Pages
<PAGE>
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
Not applicable.
Item 2. Change in Securities.
Not applicable.
Item 3. Defaults Upon Senior Securities.
Not applicable.
Item 4. Submission of Matters to a Vote of Security Holders.
Not applicable.
Item 5. Other Information.
Not applicable.
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibits: Not applicable.
(b) Reports on Form 8-K:
(1) Item 5 regarding the Company's subsidiary,
HealthAxis.com, Inc. completed the private
placement of $8.8 million of HealthAxis Series C
Preferred Stock filed on March 30, 1999.
(2) Item 5 regarding the Company's subsidiary,
Health Axis.com, Inc. completed the private
equity placement of $6.2 million of HealthAxis
common stock filed on May 13, 1999.
Page 34 of 35 Pages
<PAGE>
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Provident American Corporation
By: /s/ Alvin H. Clemens
-----------------------------------------------------
Alvin H. Clemens, Chairman of the Board of Directors,
President and Chief Executive Officer
By: /s/ Anthony R. Verdi
-----------------------------------------------------
Anthony R. Verdi, Chief Operating Officer
By: /s/ Francis L. Gillan III
-----------------------------------------------------
Francis L. Gillan III, Chief Financial Officer and
Treasurer
Date: May 17, 1999
<PAGE>
EXHIBIT 11
<TABLE>
<CAPTION>
(In thousands except per share data) Three Months Ended March 31,
1999 1998
- -----------------------------------------------------------------------------------------------------
Primary Earnings (Loss) Per Share
<S> <C> <C>
NET INCOME (LOSS) APPLICABLE TO COMMON STOCK: $ (3,031) $ 2,636
- -----------------------------------------------------------------------------------------------------
WEIGHTED AVERAGE SHARES:
Common stock 11,614 10,173
Common stock equivalents applicable to stock options and warrants * *
- -----------------------------------------------------------------------------------------------------
Total 11,614 10,173
- -----------------------------------------------------------------------------------------------------
PRIMARY EARNINGS (LOSS) PER SHARE: $ (0.26) $ 0.26
- -----------------------------------------------------------------------------------------------------
Fully Diluted Earnings (Loss) Per Share
NET INCOME (LOSS) APPLICABLE TO COMMON STOCK: $ (3,031) $ 2,636
- -----------------------------------------------------------------------------------------------------
WEIGHTED AVERAGE SHARES:
Common stock 11,614 10,173
Common stock equivalents applicable to stock options and warrants * 1,614
- -----------------------------------------------------------------------------------------------------
Total 11,614 11,787
- -----------------------------------------------------------------------------------------------------
FULLY DILUTED EARNINGS (LOSS) PER SHARE: $ (0.26) $ 0.22
- -----------------------------------------------------------------------------------------------------
* Anti-dilutive; therefore effects have been excluded.
</TABLE>
<TABLE> <S> <C>
<ARTICLE> 7
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-1999
<PERIOD-END> MAR-31-1999
<DEBT-HELD-FOR-SALE> 30,842
<DEBT-CARRYING-VALUE> 0
<DEBT-MARKET-VALUE> 0
<EQUITIES> 0
<MORTGAGE> 278
<REAL-ESTATE> 0
<TOTAL-INVEST> 31,933
<CASH> 15,643
<RECOVER-REINSURE> 36,513
<DEFERRED-ACQUISITION> 2,213
<TOTAL-ASSETS> 110,624
<POLICY-LOSSES> 42,815
<UNEARNED-PREMIUMS> 0
<POLICY-OTHER> 32,936
<POLICY-HOLDER-FUNDS> 4,835
<NOTES-PAYABLE> 1,267
0
557
<COMMON> 1,179
<OTHER-SE> 2,783
<TOTAL-LIABILITY-AND-EQUITY> 110,623
1,713
<INVESTMENT-INCOME> 924
<INVESTMENT-GAINS> 0
<OTHER-INCOME> 296
<BENEFITS> 2,141
<UNDERWRITING-AMORTIZATION> 322
<UNDERWRITING-OTHER> 5,187
<INCOME-PRETAX> (3,218)
<INCOME-TAX> 15
<INCOME-CONTINUING> (3,233)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (2,867)
<EPS-PRIMARY> (0.26)
<EPS-DILUTED> (0.26)
<RESERVE-OPEN> 0
<PROVISION-CURRENT> 0
<PROVISION-PRIOR> 0
<PAYMENTS-CURRENT> 0
<PAYMENTS-PRIOR> 0
<RESERVE-CLOSE> 0
<CUMULATIVE-DEFICIENCY> 0
</TABLE>
